02-08-2023 | Mouser Electronics | Test & Measurement
Mouser has released its latest instalment of the Empowering Innovation Together series revealing the transformative potential of digital therapeutics. The company explores the bridge between technology and medical devices to find how these parts and components can work together to deliver a more personalised and accessible means of healthcare.
The medical industry is continually evolving, and technology has become a crucial aspect in transforming traditional methods. Digital therapeutics have emerged as an efficient approach that delivers the potential to reach more patients, monitor conditions in real time, and lower the financial barriers to accessing medical care. To support this shift, the company and its industry-leading supplier partners have united to share their collective expertise and facilitate a more comprehensive method of personal health.
The latest series instalment includes a brand-new podcast episode from The Tech Between Us, and a second episode from In Between The Tech, featuring respected guests from the Digital Medicine Society and Freespira. Each episode breaks down the meaning of digital therapeutics and the cutting-edge solutions it has the potential to provide. Through these episodes, listeners will attain a comprehensive understanding of the technical hardware and software aspects of engineering design, together with the current industry challenges facing this area.
The articles, case study and infographics provide a comprehensive exploration of the present market landscape while also offering an optimistic outlook on future prospects, such as advancements in wearable technology, FDA approval procedures, and the diverse spectrum of treatments it can facilitate. The range of content helps supply a solid foundation and raise awareness among designers about how to integrate modern solutions into digital therapeutic devices.
This instalment is sponsored by the company's valued partners ams Osram, Microchip Technology, Bourns, Murata, NXP Semiconductors, Molex, and Renesas.
